Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesBen‐Quan Shen, Jagath R. Junutula, Keyang Xu et al.|Nature Biotechnology|2012Cited by 997
Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug SelectionAndrew G. Polson, Allen Ebens, Jill Calemine-Fenaux et al.|Cancer Research|2009Cited by 248
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer DiseaseEdmond Teng, Carlo de Lena, Michael Dolton et al.|JAMA Neurology|2022Cited by 188
Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonismStephen Schauer, Anne Biever, Chang Hoon Cho et al.|Alzheimer s & Dementia|2024Cited by 5